nanosynth enters new JV agreement with Volz Holdings to produce antiviral HVAC filtration media

nanosynth group plc (LON:NNN) the AIM quoted company has announced that it has entered into a new Joint Venture Agreement with, inter alia, Volz Holding v.o.s forming the basis upon which the Parties intend to develop, market and sell an anti-pathogenic product for the global filtration market. The Company will initially own 51% of the JV.

nanosynth and Volz have each agreed to licence their respective proprietary filtration and manufacturing technologies to the JV for the purpose of producing an anti-pathogen product for the global filtration market. Specifically, P2F have licenced their antipathogenic IP (PCT/GB2021/052733, NANOPARTICLES FOR USE IN ANTI PATHOGENIC APPLICATIONS) to the JV.  The JV agreement has been entered into on the basis of an agreed business plan and marketing and sales strategy. Each of the Parties will be represented on the JV board of directors.

Up to £50,000 of funding for initial working capital for the JV will be provided by the Company under the terms of a loan agreement which has also been entered into.

The Volz Group is predominately a major manufacturer of air filtration media and filter products for use in HVAC systems, with production facilities in Germany, Slovakia and the U.K. totalling more than 80,000m2.  The group has a diversified platform and specialist Tier 1 CNC engineering processing capabilities.

Further updates on the progress of the JV will be made as and when significant milestones are achieved.

Mark Duffin, nanosynth CEO commented: “I am delighted to be able to report the signing of the JV agreement with Volz which has the potential for us to develop an outstanding HVAC product at a time of great need around the globe. With the unfortunate prospect of further COVID variants likely in the future, we envisage excellent longer term sales prospects. We very much look forward to working with Volz on this innovative project using our proprietary technology.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Nanosynth Group plc

    More articles like this

    Nanosynth Group plc

    Nanotechnology in the nutricosmetics industry

    Nanotechnology for Nutricosmetics Nanocarriers are ubiquitous within nanomedicine; however, with skin quality and health in high demand for consumers, these fields have overlapped. The use of nanotechnology and nanoformulations as delivery systems for improving the performance of active

    Nanosynth Group plc

    Nanotechnology in cosmetics

    Nanotechnology is the science of manipulating atoms and molecules in the nanoscale – 80,000 times smaller than the width of a human hair. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by

    Nanosynth Group plc

    nanosynth group enter funding arrangements with Lanstead

    nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced a conditional subscription to raise £2,942,500 through the issue of 535,000,000 new ordinary shares

    Nanosynth Group plc

    Nanoparticles boost anti-cancer immunity

    The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs

    Nanosynth Group plc

    Improving crop resilience with nanoparticles

    Materials that can carry CRISPR gene-editing into plant cells could be key in the fight against global hunger. There were sceptics when Michael Strano and his colleagues published their method for using nanoparticles to alter the biology of

    Nanosynth Group plc

    How silicate nanoparticles help save historic buildings

    Constructions made of porous rock may weather over time. TU Wien (Vienna) researchers have now thoroughly examined how silicate nanoparticles can help save them for the first time. Several historical buildings were made of limestone, such as Vienna’s St. Stephen’s

    Nanosynth Group plc

    Nanoparticles can save historic buildings

    Many historical buildings were built of limestone, such as Vienna’s St. Stephen’s Cathedral. Limestone is easy to work with, but does not withstand weathering well. It consists mainly of calcite minerals that are relatively weakly bound to each

    Nanosynth Group plc

    Role of nanotechnology in management of plant viral diseases

    Plant viral diseases create massive economic damages and endanger the sustainability of agriculture. Nanotechnology is an emerging agronomy technique for plant viral disease control as nanoparticles can be utilized in pest control systems as nano insecticides, medicine delivery

    Nanosynth Group plc

    Nanoparticles can be triggered to release anti-cancer microRNA

    Study shows that nanoparticles release an anti-cancer microRNA inside lung cancer cells when stimulated using an alternating magnetic field. Researchers are pursuing ever-more sophisticated treatments to tackle lung cancer. Traditional chemotherapy can have serious side-effects throughout the body,

    Nanosynth Group plc

    Nanosynth Group “rapid progress is being made”

    Nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced a strategic update further to its notification of 1 June 2022. The business

    Nanosynth Group plc

    Nanosynth AGM to be held on 26 July 2022

    Nanosynth Group plc (LON:NANO) the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, announces that the date of the Company’s AGM has been changed. The Company’s Annual General

    No more posts to show